Neuraptive Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Neuraptive Therapeutics, Inc. - overview
Established
2016
Location
Lafayette, CO, US
Primary Industry
Pharmaceuticals
About
Founded in 2016 and based in Colorado, US, Neuraptive Therapeutics, Inc. is a developer of products for nerve repair market use. The company's products include AxoFuse, a nerve repair system which helps patients with peripheral nerve injuries to prevent limb atrophy and nerve degeneration; AxoTrim, a surgical instrument to assist in the nerve preparation for suturing; AxoBond, secures a surgically repaired nerve during recovery, and AxoFuse to be used in clinical trials.
Current Investors
Central Texas Angel Network, New Rhein Healthcare Investors
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development, Biomaterials
Website
www.neuraptive.com
Verticals
HealthTech, Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.